Literature DB >> 24371617

Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide (VPCBAE) in the management of three patients with small-cell carcinoma of the ovary.

John J Wallbillich1, Alpa M Nick2, Pedro T Ramirez2, Jack L Watkins3, Elizabeth D Euscher4, Kathleen M Schmeler2.   

Abstract

► Ovarian small-cell carcinoma of the hypercalcemic type is a rare neoplasm with no standard treatment. ► The chemotherapy regimen including vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin and etoposide (VPCBAE) has limited toxicities and was effective in the 3 patients described in this case report.

Entities:  

Keywords:  Chemotherapy; Ovarian cancer; Small cell

Year:  2012        PMID： 24371617      PMCID： PMC3860786          DOI： 10.1016/j.gynor.2012.02.001

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  7 in total

1.  Case records of the Massachusetts General Hospital. Case 8-2010. A 22-year-old woman with hypercalcemia and a pelvic mass.

Authors:  Robert H Young; Annekathryn Goodman; Richard T Penson; Anthony H Russell; Raul N Uppot; Rosemary H Tambouret
Journal:  N Engl J Med       Date:  2010-03-18       Impact factor: 91.245

2.  Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.

Authors:  M L Harrison; P Hoskins; A du Bois; M Quinn; G J S Rustin; J A Ledermann; S Baron-Hay; M L Friedlander
Journal:  Gynecol Oncol       Date:  2006-02       Impact factor: 5.482

3.  Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy.

Authors:  K Tewari; C Brewer; F Cappuccini; C Macri; L W Rogers; M L Berman
Journal:  Gynecol Oncol       Date:  1997-09       Impact factor: 5.482

4.  Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary.

Authors:  E K Senekjian; P A Weiser; A Talerman; A L Herbst
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

5.  Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.

Authors:  Lori E Weinberg; John R Lurain; Diljeet K Singh; Julian C Schink
Journal:  Gynecol Oncol       Date:  2011-01-21       Impact factor: 5.482

Review 6.  Clinical management of ovarian small-cell carcinoma of the hypercalcemic type: a proposal for conservative surgery in an advanced stage of disease.

Authors:  Ramon H M Dykgraaf; Diederick de Jong; Mirjam van Veen; Patricia C Ewing-Graham; Theo J M Helmerhorst; Maria E L van der Burg
Journal:  Int J Gynecol Cancer       Date:  2009-04       Impact factor: 3.437

7.  Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases.

Authors:  R H Young; E Oliva; R E Scully
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394
  7 in total
  7 in total

1.  Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.

Authors:  Elizabeth K Lee; Katharine M Esselen; David L Kolin; Larissa J Lee; Ursula A Matulonis; Panagiotis A Konstantinopoulos
Journal:  JCO Precis Oncol       Date:  2020-06-24

2.  Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.

Authors:  D Callegaro-Filho; D M Gershenson; A M Nick; M F Munsell; P T Ramirez; P J Eifel; E D Euscher; R M Marques; S M Nicolau; K M Schmeler
Journal:  Gynecol Oncol       Date:  2015-11-04       Impact factor: 5.482

3.  Ovarian Small Cell Carcinoma of Hypercalcemic Type in an Adolescent Girl.

Authors:  Divya Khosla; Nalini Gupta; Abin Koshy; Ashwani Dalal; A K Pandey; Kislay Dimri
Journal:  J Obstet Gynaecol India       Date:  2018-02-02

Review 4.  Primary ovarian small cell carcinoma of pulmonary type with coexisting endometrial carcinoma in a breast cancer patient receiving tamoxifen: A case report and literature review.

Authors:  Lei Yin; Jianning Li; Yunhai Wei; Dejian Ma; Yamei Sun; Yanlai Sun
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

5.  Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.

Authors:  Brooke E Sanders; Rebecca Wolsky; Elizabeth S Doughty; Kristen L Wells; Debashis Ghosh; Lisa Ku; Joseph G Pressey; Benjamin B Bitler; Lindsay W Brubaker
Journal:  Gynecol Oncol Rep       Date:  2022-10-06

6.  Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.

Authors:  Somayyeh Fahiminiya; Leora Witkowski; Javad Nadaf; Jian Carrot-Zhang; Catherine Goudie; Martin Hasselblatt; Pascal Johann; Marcel Kool; Ryan S Lee; Tenzin Gayden; Charles W M Roberts; Jaclyn A Biegel; Nada Jabado; Jacek Majewski; William D Foulkes
Journal:  Oncotarget       Date:  2016-01-12

7.  Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review.

Authors:  Jian-Jun Wang; Qi Liu; Nan Wu; Xiao-Die Zhou; Hai Wang; Xuan Wang; Pin Tu; Xiao-Jun Zhou; Qun-Li Shi
Journal:  Onco Targets Ther       Date:  2016-03-11       Impact factor: 4.147
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.